Figure 6
P2Et extract retard initially primary tumor growth but increase survival in triple negative human breast cancer. (a) Experimental scheme of treatment. MDA-MB-468 cells were inoculated into the mouse mammary gland, 8 days later, the mice were treated with PBS (negative control) or 18.7 mg/Kg of P2Et extract twice a week until endpoint. (b) Tumor growth (mm3) of MDA-MB-468 control (PBS) mice or mice treated with P2Et extract. Multiple t-test with Holm-Sidak method correction was performed assuming significance of α = 0.05. *p < 0.05.
